Volga | Technology & innovation | Finance, business

Udmurtia scientists offer biochips for cell diagnostics

31 Mar '16
Scientists in Izhevsk, in Udmurtia in the Volga area, have developed biochips to screen cells, which analysts believe could challenge competitors in both domestic and international markets.

Izhevsk biochips have certain advantages over their foreign analogs, said Alexander Shishkin, the head of an experimental laboratory at the Izhevsk State Medical Academy.

The scientist noted that existing methods are relatively expensive and enable the identification of a limited number of antigens. In our situation, everything is pinpointed easily in an ordinary lab environment; the system enables the identification of several dozen antigens, and at a very low cost, Mr. Shishkin said.

The system is said to enable all-out cell examination, as the biochip is good enough for sweeping screening of populations to find most widespread cell pathologies.

The production cost of a biochip is between nine cents and just under one dollar, with the average market price of $5.5-7 apiece. According to Mr. Shishkin, Russian market demand for such a biochip is between 200,000 and 300,000 chips a year in hematology, between 20 and 30 million in clinical immunology, and, if used for widespread federal healthcare programs, about 100 million biochips or more a year.

The payback period is projected to be four to six years.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
Find Related Content

Tags: cell (69) / biochip (5) / Alexander Shishkin (0) /

Latest News: Volga
19 Jan '18 | Technology & innovation
12 May '17 | Technology & innovation | Industry, manufacturing
21 Apr '17 | Technology & innovation
14 Apr '17 | Finance, business | Industry, manufacturing
10 Jan '17 | Technology & innovation

Feature stories

21 Nov '17
Russian scientists have come up with what they say is...
7 Sep '17
26 Jul '17
Scientists at Tomsk Polytechnic (TPU) in Siberia have...
Search (News archive - 21211)
Independent Software Developers Forum
Marchmont News

Latest News

20 Feb '18
Yandex, the NASDAQ-listed Russian search giant, and...
19 Feb '18
Scientists in Vladivostok, in Russias Far East, have...
16 Feb '18
Hemopharm, a Russian biotech company, is developing a...

Most read stories from last week

19 Feb '18
Scientists in Vladivostok, in Russias Far East, have...
20 Feb '18
Yandex, the NASDAQ-listed Russian search giant, and...